
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A scoping review of literature on clozapine from former USSR states published in Russian language
O.O. Kirilochev, Егор Чумаков, Nazar Kuzo, et al.
Schizophrenia Research (2023) Vol. 268, pp. 38-47
Closed Access | Times Cited: 7
O.O. Kirilochev, Егор Чумаков, Nazar Kuzo, et al.
Schizophrenia Research (2023) Vol. 268, pp. 38-47
Closed Access | Times Cited: 7
Showing 7 citing articles:
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 12
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 12
Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety
Carlos De las Cuevas, Emílio J. Sanz, José de León
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2261-2280
Open Access | Times Cited: 4
Carlos De las Cuevas, Emílio J. Sanz, José de León
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2261-2280
Open Access | Times Cited: 4
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Promoting safer and wider worldwide use of clozapine
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data
Carlos De las Cuevas, Emílio J. Sanz, Sara Jiménez‐Fernández, et al.
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 2
Carlos De las Cuevas, Emílio J. Sanz, Sara Jiménez‐Fernández, et al.
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 2
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards
Nazar Kuzo, Bohdan Blyzniuk, Егор Чумаков, et al.
Schizophrenia Research (2023)
Open Access | Times Cited: 2
Nazar Kuzo, Bohdan Blyzniuk, Егор Чумаков, et al.
Schizophrenia Research (2023)
Open Access | Times Cited: 2